gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Blinatumomab binds CD3 on T cells to activate and redirect them to lyse CD19+ target cells via perforin/granzyme; CD3+ T cells are not themselves killed.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
TCR-CD3 complex subunits (e.g., CD3E/CD3D/CD3G/CD247) not specified
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06308588
disease_id_num_tar_ref
3125
drug_id_num_tar_ref
8392